IE920229A1 - Regulation of nucleic acid translation - Google Patents

Regulation of nucleic acid translation

Info

Publication number
IE920229A1
IE920229A1 IE022992A IE920229A IE920229A1 IE 920229 A1 IE920229 A1 IE 920229A1 IE 022992 A IE022992 A IE 022992A IE 920229 A IE920229 A IE 920229A IE 920229 A1 IE920229 A1 IE 920229A1
Authority
IE
Ireland
Prior art keywords
region
rna
responsive
inhibitor
responsive rna
Prior art date
Application number
IE022992A
Other languages
English (en)
Original Assignee
Us Biochemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Biochemical Corp filed Critical Us Biochemical Corp
Publication of IE920229A1 publication Critical patent/IE920229A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IE022992A 1991-01-25 1992-01-24 Regulation of nucleic acid translation IE920229A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64610991A 1991-01-25 1991-01-25

Publications (1)

Publication Number Publication Date
IE920229A1 true IE920229A1 (en) 1992-07-29

Family

ID=24591791

Family Applications (1)

Application Number Title Priority Date Filing Date
IE022992A IE920229A1 (en) 1991-01-25 1992-01-24 Regulation of nucleic acid translation

Country Status (7)

Country Link
EP (1) EP0568641A4 (ja)
JP (1) JPH06505161A (ja)
AU (1) AU1341092A (ja)
CA (1) CA2100251A1 (ja)
IE (1) IE920229A1 (ja)
PT (1) PT100052A (ja)
WO (1) WO1992013070A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4234293A (en) * 1992-05-14 1993-12-13 Ribozyme Pharmaceuticals, Inc. Virus resistant plants containing inducible cytotoxic mrnas
EP0707638A4 (en) * 1992-12-04 1998-05-20 Innovir Lab Inc REGULABLE NUCLEIC ACID FOR THERAPEUTIC USE AND METHODS OF USE THEREOF
AU8088794A (en) * 1993-10-25 1995-05-22 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Plasmids for efficient expression of synthetic genes in (e. coli)
US5631148A (en) * 1994-04-22 1997-05-20 Chiron Corporation Ribozymes with product ejection by strand displacement
BR9810460A (pt) 1997-06-25 2001-11-27 Charles Allen Black Jr Cassete de expressão mascarado e métodos paracontrolar a expressão e produzir uma proteìnade interesse
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
CZ295108B6 (cs) 1998-03-20 2005-05-18 Benitec Australia Ltd Syntetický gen obsahující dispergovanou nebo cizorodou deoxyribonukleovou molekulu a genový konstrukt obsahující tento syntetický gen
US8598332B1 (en) 1998-04-08 2013-12-03 Bayer Cropscience N.V. Methods and means for obtaining modified phenotypes
ATE507299T1 (de) 1998-04-08 2011-05-15 Commw Scient Ind Res Org Verfahren und mittel zum erhalt von veränderten phänotypen
US20040214330A1 (en) 1999-04-07 2004-10-28 Waterhouse Peter Michael Methods and means for obtaining modified phenotypes
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
EP3218483A4 (en) 2014-11-14 2018-07-18 Ionis Pharmaceuticals, Inc. Compounds and methods for the modulation of proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820639A (en) * 1985-12-04 1989-04-11 Massachusetts Institute Of Technology Process for enhancing translational efficiency of eukaryotic mRNA
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
WO1989000604A1 (en) * 1987-07-13 1989-01-26 Interferon Sciences, Inc. Method for improving translation efficiency

Also Published As

Publication number Publication date
EP0568641A1 (en) 1993-11-10
CA2100251A1 (en) 1992-07-26
PT100052A (pt) 1993-03-31
AU1341092A (en) 1992-08-27
JPH06505161A (ja) 1994-06-16
WO1992013070A1 (en) 1992-08-06
EP0568641A4 (en) 1994-09-14

Similar Documents

Publication Publication Date Title
Heidenreich et al. Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1.
US5874414A (en) Trans-splicing ribozymes
US5976879A (en) Antisense oligonucleotides which combat aberrant splicing and methods of using the same
US6107062A (en) Antisense viruses and antisense-ribozyme viruses
US5246921A (en) Method for treating leukemias
US5683873A (en) EGS-mediated inactivation of target RNA
DK2363479T3 (en) Oligoribonucleotide for inhibiting the expression of a defined gene
US6057153A (en) Stabilized external guide sequences
US5667969A (en) Alteration of sequence of a deleterious target molecule by ribozyme catalyzed trans-splicing
Borovjagin et al. U3 small nucleolar RNA is essential for cleavage at sites 1, 2 and 3 in pre-rRNA and determines which rRNA processing pathway is taken in Xenopus oocytes
IE920229A1 (en) Regulation of nucleic acid translation
CA2345936A1 (en) Production of ssdna in a cell
AU4119893A (en) Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
CA2135499A1 (en) Method and reagent for inhibiting cancer development
KR900014591A (ko) Rna 작용을 억제하는 유전 단위
WO1992000080A1 (en) Method for treating leukemias
CA2135643A1 (en) Virus resistant plants
Lim et al. Sequence-independent inhibition of RNA transcription by DNA dumbbells and other decoys
EP1366151B1 (en) Prna chimera
US6740750B1 (en) Expression systems for functional nucleic acid expression
EP2266995B1 (en) Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
US7045293B2 (en) Alteration of sequence of a target molecule
US20070160581A1 (en) Production of ssDNA in vivo
AU2004205192B2 (en) Production of ssDNA in vivo
Thompson [14] Strategies to express structural and catalytic RNAs in mammalian cells